Evidence map›Paper›PMID 32407296›Full record

ArticleJCI insight2020

Regulation of bile duct epithelial injury by hepatic CD71+ erythroid cells.

Li Yang, Pranavkumar Shivakumar, Jeremy Kinder, Sing Sing Way, Bryan Donnelly, Reena Mourya, Zhenhua Luo, Jorge A Bezerra

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in JCI insight, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Immunoregulation role of the erythroid cells.Frontiers in immunology · 2024
    Review
  7. Article
  8. CD71Journal for immunotherapy of cancer · 2023
    Article
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Article
  15. CD71Frontiers in immunology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Li YangDivision of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center (CCHMC) and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Pranavkumar ShivakumarDivision of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center (CCHMC) and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Jeremy KinderDivision of Infectious Diseases and Perinatal Institute and.
Sing Sing WayDivision of Infectious Diseases and Perinatal Institute and.
Bryan DonnellyDivision of Pediatric and Thoracic Surgery, CCHMC, Ohio, USA.
Reena MouryaDivision of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center (CCHMC) and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Zhenhua LuoDivision of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center (CCHMC) and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Jorge A BezerraDivision of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center (CCHMC) and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Cincinnati Children's Hospital Medical Center · USPerinatal Institute · GBCommunications Consortium Media Center · US

Funding

Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Alexander Miethke · 2007 to 2026
$24.4M
Immunologic Dysfunction in Biliary AtresiaR01DK064008 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI DENSON, LEE ARMISTEAD · 2003 to 2022
$6.7M
Biological Basis of Phenotypes and Clinical Outcomes in Biliary AtresiaR01DK083781 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI BEZERRA, JORGE A. · 2009 to 2023
$6.1M
NIDDK NIH HHS P30 DK078392NIDDK NIH HHS R01 DK064008NIDDK NIH HHS R01 DK083781
6 · The paper itself

Abstract

Extramedullary hematopoietic cells are present in the liver of normal neonates in the first few days of life and persist in infants with biliary atresia. Based on a previous report that liver genes are enriched by erythroid pathways, we examined the liver gene expression pattern at diagnosis and found the top 5 enriched pathways are related to erythrocyte pathobiology in children who survived with the native liver beyond 2 years of age. Using immunostaining, anti-CD71 antibodies identified CD71+ erythroid cells among extramedullary hematopoietic cells in the livers at the time of diagnosis. In mechanistic experiments, the preemptive antibody depletion of hepatic CD71+ erythroid cells in neonatal mice rendered them resistant to rhesus rotavirus-induced (RRV-induced) biliary atresia. The depletion of CD71+ erythroid cells increased the number of effector lymphocytes and delayed the RRV infection of livers and extrahepatic bile ducts. In coculture experiments, CD71+ erythroid cells suppressed the activation of hepatic mononuclear cells. These data uncover an immunoregulatory role for CD71+ erythroid cells in the neonatal liver.

Indexed as

Bile Ducts, ExtrahepaticAnimalsAnimals, NewbornBiliary AtresiaDisease Models, AnimalErythroid CellsHumansLiverMiceMice, Inbred BALB CCellular immune responseHepatitisHepatologyMouse models

Identifiers

PMID32407296
PMCPMC7308060
OpenAlexW3025545149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.